Browse Drug Recalls
1,681 FDA drug safety recalls.
FDA Drug Recall Enforcement Database
Browse 1,681 FDA drug recall enforcement actions. Each entry includes the product description, reason for recall, classification (Class I through III based on severity), recalling firm, and distribution details. Use the filters below to search by year, classification, state, or keyword.
Drug Safety Recalls
Browse 1,681 FDA drug recalls in 2018.
| Date | Product | Reason | Class | Firm |
|---|---|---|---|---|
| May 1, 2018 | Loxapine Capsules, USP 50 mg, packaged in 100 Unit Dose capsules, Rx only, Ma... | GMP Deviations: a recent FDA inspection of the manufacturing site revealed multiple cGMP violatio... | Class II | Mylan Institutional, Inc. (d.b.a. UDL Laborator... |
| May 1, 2018 | Loxapine Capsules, USP 25 mg, packaged in 100 Unit Dose Capsules, Rx only, Ma... | GMP Deviations: a recent FDA inspection of the manufacturing site revealed multiple cGMP violatio... | Class II | Mylan Institutional, Inc. (d.b.a. UDL Laborator... |
| May 1, 2018 | Ampicillin and Sulbactam for Injection, USP, 3 gram*s/vial, For Intramuscular... | Presence of Particulate Matter: confirmed customer report of the presence of visible particulate ... | Class I | AuroMedics Pharma LLC |
| May 1, 2018 | Piperacillin and Tazobactam for Injection, USP 3.375 grams per vial, For Intr... | Presence of Particulate Matter: confirmed customer report for presence of visible particulate mat... | Class I | AuroMedics Pharma LLC |
| Apr 30, 2018 | Lidocaine Patch 5% (700 mg) ,(NDC 0591-3525-11), 30 envelopes containing 1 pa... | Failed Stability Specifications | Class III | Teva Pharmaceuticals USA |
| Apr 30, 2018 | PrednisoLONE Sodium Phosphate Orally Disintegrating Tablets 15 mg, Rx Only, ... | CGMP Deviations | Class II | Mylan Pharmaceuticals Inc. |
| Apr 30, 2018 | PrednisoLONE Sodium Phosphate Orally Disintegrating Tablets 10 mg, Rx Only, 4... | CGMP Deviations | Class II | Mylan Pharmaceuticals Inc. |
| Apr 30, 2018 | PrednisoLONE Sodium Phosphate Orally Disintegrating Tablets, 30 mg, Rx Only,... | CGMP Deviations | Class II | Mylan Pharmaceuticals Inc. |
| Apr 27, 2018 | Docetaxel injection concentrate, 20 mg/mL, 1 mL vial, Rx only, Winthrop U.S. ... | Superpotent drug: over-concentrated vials of Docetaxel injection concentrate 20 mg/mL may have be... | Class II | Sanofi-Aventis U.S. LLC |
| Apr 26, 2018 | Macroaggregated albumin (MAA) kit (for the preparation of Tc99m MAA), Aggrega... | Lack of Assurance of Sterility | Class II | Coast Quality Pharmacy LLC |
| Apr 26, 2018 | Riomet (metformin hydrochloride oral solution), 500 mg/5 mL (16 fl. oz.), 473... | Labeling: Not Elsewhere Classified: Sun Pharma has decided to initiate this recall in response to... | Class III | Sun Pharmaceutical Industries, Inc. |
| Apr 24, 2018 | Acetaminophen 300 mg with Codeine Phosphate 30 mg tablets, USP, 20-count M-Pa... | Labeling: Not Elsewhere Classified: due to a labeled declaration of; Store at 15¿C to 30¿C (59¿F... | Class II | Prescript Pharmaceuticals, Inc. |
| Apr 24, 2018 | Methylcobalamin for injection, 1mg/mL and 10 mg/mL, Sterile injectable, Vital... | Lack of assurance of sterility: Upon review of recent 3rd party environmental certification docum... | Class II | Vitalab Pharmacy, Inc |
| Apr 24, 2018 | Papaverine 30mg/Phentolamine 1.5mg/Prostaglandin 50mcg/mL, sterile injectable... | Lack of assurance of sterility: Upon review of recent 3rd party environmental certification docum... | Class II | Vitalab Pharmacy, Inc |
| Apr 24, 2018 | Acetaminophen 300 mg with Codeine Phosphate 30 mg tablets, USP, 20-count M-Pa... | Labeling: Not Elsewhere Classified: due to a labeled declaration of; Store at 15¿C to 30¿C (59¿F... | Class II | Prescript Pharmaceuticals, Inc. |
| Apr 24, 2018 | Methionine 25mg/Inositol 50mg/Choline 50mg/Cyanocobalamin 1mg/ml, Sterile inj... | Lack of assurance of sterility: Upon review of recent 3rd party environmental certification docum... | Class II | Vitalab Pharmacy, Inc |
| Apr 24, 2018 | Amlodipine and Benazapril HCL Capsules, USP, 5 mg/40 mg, 100 count bottles, M... | cGMP Deviations; cleaning processes for equipment used to manufacture the specified batches was n... | Class II | Mylan Pharmaceuticals Inc. |
| Apr 24, 2018 | Amlodipine and Benazapril HCL Capsules, USP, 5 mg/10 mg, 100 count bottles, M... | cGMP Deviations; cleaning process for equipment used to manufacture the specified batches was not... | Class II | Mylan Pharmaceuticals Inc. |
| Apr 24, 2018 | Chlorhexidine 0.12% liquid, 473 MILLITERS. Rx Only. Mnfct for: XTTRUM Laborat... | Labeling: Not Elsewhere Classified: due to a labeled declaration of; Store at 15¿C to 30¿C (59¿F... | Class II | Prescript Pharmaceuticals, Inc. |
| Apr 24, 2018 | Loxapine Capsules, USP 50 mg, Rx Only, 100-count bottles, NDC 0378-7050-01 | CGMP Deviations | Class II | Mylan Pharmaceuticals Inc. |
| Apr 24, 2018 | Papaverine 9mg/Phentolamine 1mg/Atropine 0.1mg/Prostaglandinl 10mcg/ml, steri... | Lack of assurance of sterility: Upon review of recent 3rd party environmental certification docum... | Class II | Vitalab Pharmacy, Inc |
| Apr 24, 2018 | Papaverine 30mg/Phentolamine 2mg/Prostaglandin 20mcg/mL, Papaverine 30mg/Phe... | Lack of assurance of sterility: Upon review of recent 3rd party environmental certification docum... | Class II | Vitalab Pharmacy, Inc |
| Apr 24, 2018 | Clindamycin 150 mg capsules, USP, 30-count M-Pak container. Mnfct by: Lannet... | Labeling: Not Elsewhere Classified: due to a labeled declaration of; Store at 15¿C to 30¿C (59¿F... | Class II | Prescript Pharmaceuticals, Inc. |
| Apr 24, 2018 | Loxapine Capsules, USP 25 mg, Rx Only, 100-count bottles, NDC 0378-7025-01 | CGMP Deviations | Class II | Mylan Pharmaceuticals Inc. |
| Apr 24, 2018 | Alprostadil 20 mcg/mL, Sterile injectable, Vitalab Pharmacy, Inc | Lack of assurance of sterility: Upon review of recent 3rd party environmental certification docum... | Class II | Vitalab Pharmacy, Inc |
| Apr 24, 2018 | Clindamycin 300 mg capsules, USP, 28-count M-Pak containers, Rx Only. Mnfct f... | Labeling: Not Elsewhere Classified: due to a labeled declaration of; Store at 15¿C to 30¿C (59¿F... | Class II | Prescript Pharmaceuticals, Inc. |
| Apr 23, 2018 | Diltiazem CD (Diltiazem Hydrochloride Extended-Release Capsules, USP) 180 mg,... | Failed Dissolution Specifications. High dissolution results were obtained during stability testing. | Class III | Mckesson Packaging Services |
| Apr 23, 2018 | Diltiazem HCl Extended-Release Capsules, USP 240 mg, 100-count bottles, Rx On... | Failed Dissolution Specifications. High dissolution results were obtained during stability testing. | Class III | Mckesson Packaging Services |
| Apr 23, 2018 | Metoprolol Succinate Extended-Release Tablets, USP, 100 mg, 100 Tablets bottl... | Presence of Foreign Tablets/Capsules: One foreign tablet identified as Clopidogrel 75 mg was foun... | Class II | Dr. Reddy's Laboratories, Inc. |
| Apr 23, 2018 | Diltiazem HCl Extended-Release Capsules, USP 120 mg, 100-count bottles, Rx on... | Failed Dissolution Specifications. High dissolution results were obtained during stability testing. | Class III | Mckesson Packaging Services |
| Apr 20, 2018 | Diclofenac Sodium and Misoprostol Delayed Release Tablets 75 mg/0.2 mg, 60-co... | Labeling: Label Mix-Up: bottle labeled as Diclofenac Sodium and Misoprostol 75 mg/0.2 mg containe... | Class II | Exela Pharma Sciences LLC |
| Apr 19, 2018 | Sulfamethoxazole and Trimethoprim Tablets USP, 800 mg/160 mg, Rx Only, 500-co... | Presence of Foreign Substance:Sun Pharma is recalling one (1) lot of Sulfamethoxazole and Trimeth... | Class II | Sun Pharmaceutical Industries, Inc. |
| Apr 17, 2018 | Aptensio XR (methylphenidate HCl extended-release) capsules 15 mg Rx Only 90-... | Failed Dissolution Specification: Low dissolution outside of specifications | Class III | Rhodes Pharmaceuticals, L.P. |
| Apr 16, 2018 | Euphoric Premium Male Performance Enhancer capsules, packaged in a)1-count bl... | Marketed Without An Approved NDA/ANDA: product contains undeclared sildenafil, tadalafil, and oxy... | Class I | Epic Products, LLC |
| Apr 13, 2018 | Fluocinolone Acetonide Topical Oil, 0.01% (Scalp Oil) 118.28 mL (4 fl.oz.) Rx... | Subpotent Drug | Class II | Lyne Laboratories, Inc. |
| Apr 13, 2018 | Fluocinolone Acetonide Topical Oil, 0.01% (Ear Drops) 20 mL, Rx Only, Manufac... | Subpotent Drug | Class II | Lyne Laboratories, Inc. |
| Apr 13, 2018 | OraVerse (Phentolamine Mesylate) Injection, 0.4 mg/1.7mL, packaged in a box ... | Failed Impurities/Degradation: This recall has been initiated due to an out of specification (OOS... | Class III | Septodont Inc. |
| Apr 13, 2018 | Fluocinolone Acetonide Topical Oil, 0.01% (Body Oil) 118.28 mL (4 fl. oz.) Rx... | Subpotent Drug | Class II | Lyne Laboratories, Inc. |
| Apr 13, 2018 | Calendula Cream, calendula officinalis 1X HUS-10%, 2.5 oz. tubes, Distributed... | Labeling: Labeling Error on Declared Strength; The outer carton (secondary packaging) statement o... | Class III | Boiron Inc. |
| Apr 12, 2018 | Rhino 69 Extreme 50000 packaged in 1 capsule per blister pack, Distributed by... | Marketed Without An Approved NDA/ANDA: FDA analysis found the product to contain undeclared tadal... | Class I | AMA Wholesale |
| Apr 11, 2018 | NEOstigmine Methylsulfate (1 mg/mL) 3mg per 3mL. 3mL Single Dose Syringe. Pre... | Lack of Assurance of Sterility:Microbial contamination was detected during routine testing of sub... | Class II | Premier Pharmacy Labs Inc |
| Apr 11, 2018 | Morphine Sulfate 2 mg/mL PF Injection. 1 mL in a 3ml Sterile Single-Dose Syri... | Lack of Assurance of Sterility:Microbial contamination was detected during routine testing of sub... | Class II | Premier Pharmacy Labs Inc |
| Apr 11, 2018 | Morphine Sulfate 4 mg/mL PF Injection. 1 mL in a 3ml Sterile Single-Dose Syri... | Lack of Assurance of Sterility:Microbial contamination was detected during routine testing of sub... | Class II | Premier Pharmacy Labs Inc |
| Apr 11, 2018 | Hydromorphone HCl 1 mg/mL PF INJ. 1mL in a 3mL Sterile Single-Dose Syringe. ... | Lack of Assurance of Sterility:Microbial contamination was detected during routine testing of sub... | Class II | Premier Pharmacy Labs Inc |
| Apr 10, 2018 | Kit for the Preparation of Technetium TC-99M Mebrofenin, 45 mg in 10 mL (5 co... | Failed Stability Specifications | Class II | Pharmalucence, Inc. |
| Apr 10, 2018 | Ferrous Sulfate 325 MG tablet; NDC 33261-0715-00 | Presence of Foreign Tablets/Capsules | Class III | Aidarex Pharmaceuticals LLC |
| Apr 10, 2018 | Vasopressin 50 Units added to 250 mL 0.9% Sodium Chloride Injection USP (0.2 ... | cGMP deviations | Class III | Pharmedium Services, LLC |
| Apr 9, 2018 | Daytrana (methylphenidate transdermal system) Delivers 10 mg over 9 hours (1.... | Defective Delivery System: Out of specification for adhesive transfer. | Class II | Noven Pharmaceuticals, Inc. |
| Apr 9, 2018 | Cystaran (cysteamine ophthalmic solution) 0.44%, 15 mL bottle, Rx only, Manuf... | Subpotent drug: Out of specification for an active ingredient cysteamine hydrochloride. | Class III | LEADIANT BIOSCIENCES, INC |
| Apr 6, 2018 | Triamterene and Hydrochlorothiazide Tablets, USP, 75 mg/50 mg, 500-count bott... | Cross Contamination With Other Products: presence of unrelated ingredients (i.e. traces of Lisino... | Class III | Sandoz Incorporated |
Frequently Asked Questions
When a drug safety issue is identified — through FDA inspections, laboratory testing, adverse event reports, or manufacturer quality checks — the responsible company issues a recall to remove the affected products from the market. Pharmacies pull the product from shelves, and consumers are advised to contact their healthcare provider for alternatives.
The leading causes include cGMP deviations, impurity contamination (including nitrosamines like NDMA), failed dissolution or stability testing, sterility issues, potency problems, labeling errors, and foreign particle contamination.
Use the search and filter tools on this page to look up specific medications, active ingredients, or manufacturers. Each recall entry includes the product description, lot numbers, and distribution details.